Literature DB >> 2334150

Effects of subinhibitory concentrations of vancomycin or cefamandole on biofilm production by coagulase-negative staphylococci.

W M Dunne1.   

Abstract

The density of the biofilm layer produced on a plastic surface by 23 clinical isolates and 1 reference strain of slime-positive, coagulase-negative staphylococci was measured following growth in subinhibitory concentrations (sub-MICs) of cefamandole or vancomycin ranging from 2 to 0.008 micrograms/ml. All strains were susceptible to less than or equal to 2 micrograms of each agent per ml. The mean biofilm density produced by each strain was calculated from a total of eight determinations at each sub-MIC and was compared with the mean biofilm density of a drug-free control after correcting for differences in growth. The results showed that the density of the biofilm layer produced by 10 (42%) of 24 strains and 13 (54%) of 24 strains was significantly increased (P less than 0.006) at one or more sub-MICs of cefamandole or vancomycin, respectively. In contrast, the density of the biofilm produced by 9 (38%) of 24 and 2 (8%) of 24 strains was significantly reduced at one or more sub-MICs of cefamandole and vancomycin, respectively, and the biofilm density of 7 of these strains was decreased only when the sub-MIC was one-half the MIC. The biofilm density of six strains (five versus cefamandole and one versus vancomycin) was both enhanced and reduced by different sub-MICs of the same agent. None of the strains produced a detectable biofilm at or above the MIC for the strain. These data indicate that antimicrobial agents such as cefamandole or vancomycin could potentially enhance the biofilm matrix produced by certain slime-positive, coagulase-negative staphylococci on the surface of a biomedical implant if concentrations of these agents fall below the MIC for the infecting strain.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2334150      PMCID: PMC171602          DOI: 10.1128/AAC.34.3.390

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  16 in total

1.  Characteristics of adherence to plastic tissue culture plates of coagulase-negative staphylococci exposed to subinhibitory concentrations of antimicrobial agents.

Authors:  K H Schadow; W A Simpson; G D Christensen
Journal:  J Infect Dis       Date:  1988-01       Impact factor: 5.226

2.  Usefulness of a test for slime production as a marker for clinically significant infections with coagulase-negative staphylococci.

Authors:  D S Davenport; R M Massanari; M A Pfaller; M J Bale; S A Streed; W J Hierholzer
Journal:  J Infect Dis       Date:  1986-02       Impact factor: 5.226

3.  Coagulase-negative staphylococci isolated from cerebrospinal fluid shunts: importance of slime production, species identification, and shunt removal to clinical outcome.

Authors:  J J Younger; G D Christensen; D L Bartley; J C Simmons; F F Barrett
Journal:  J Infect Dis       Date:  1987-10       Impact factor: 5.226

4.  Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of staphylococci to medical devices.

Authors:  G D Christensen; W A Simpson; J J Younger; L M Baddour; F F Barrett; D M Melton; E H Beachey
Journal:  J Clin Microbiol       Date:  1985-12       Impact factor: 5.948

Review 5.  Staphylococcus epidermidis infections.

Authors:  F D Lowy; S M Hammer
Journal:  Ann Intern Med       Date:  1983-12       Impact factor: 25.391

6.  Interference with granulocyte function by Staphylococcus epidermidis slime.

Authors:  G M Johnson; D A Lee; W E Regelmann; E D Gray; G Peters; P G Quie
Journal:  Infect Immun       Date:  1986-10       Impact factor: 3.441

7.  Clinical comparative study on the activity of cefamandole in the treatment of serious staphylococcal infections caused by methicillin-susceptible and methicillin-resistant strains.

Authors:  R F Frongillo; L Donati; G Federico; P Martino; M Moroni; L Ortona; M Palumbo; B M Pasticci; E Pizzigallo; G Privitera
Journal:  Antimicrob Agents Chemother       Date:  1986-05       Impact factor: 5.191

8.  Adherence of slime-producing strains of Staphylococcus epidermidis to smooth surfaces.

Authors:  G D Christensen; W A Simpson; A L Bisno; E H Beachey
Journal:  Infect Immun       Date:  1982-07       Impact factor: 3.441

9.  Characterization of clinically significant strains of coagulase-negative staphylococci.

Authors:  G D Christensen; J T Parisi; A L Bisno; W A Simpson; E H Beachey
Journal:  J Clin Microbiol       Date:  1983-08       Impact factor: 5.948

10.  Staphylococcal peritonitis in patients on continuous peritoneal dialysis.

Authors:  T E West; J J Walshe; C P Krol; D Amsterdam
Journal:  J Clin Microbiol       Date:  1986-05       Impact factor: 5.948

View more
  14 in total

1.  Effect of subinhibitory concentrations of cefamandole and cefuroxime on adherence of Staphylococcus aureus and Staphylococcus epidermidis to polystyrene culture plates.

Authors:  H Carsenti-Etesse; J Durant; E Bernard; V Mondain; J Entenza; P Dellamonica
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-08       Impact factor: 3.267

2.  In vitro measurement of the adherence of Staphylococcus epidermidis to plastic by using cellular urease as a marker.

Authors:  W M Dunne; E M Burd
Journal:  Appl Environ Microbiol       Date:  1991-03       Impact factor: 4.792

3.  Reduced vancomycin susceptibility in an in vitro catheter-related biofilm model correlates with poor therapeutic outcomes in experimental endocarditis due to methicillin-resistant Staphylococcus aureus.

Authors:  Wessam Abdelhady; Arnold S Bayer; Kati Seidl; Cynthia C Nast; Megan R Kiedrowski; Alexander R Horswill; Michael R Yeaman; Yan Q Xiong
Journal:  Antimicrob Agents Chemother       Date:  2013-01-07       Impact factor: 5.191

4.  AUC/MIC Pharmacodynamic Target Is Not a Good Predictor of Vancomycin Efficacy in Methicillin-Resistant Staphylococcus aureus Experimental Endocarditis.

Authors:  Ximena Castañeda; Cristina García-de-la-Mària; Oriol Gasch; Juan M Pericas; Yolanda Armero; Dolors Soy; Javier García-González; Carlos Falces; Salvador Ninot; Manel Almela; Juan Ambrosioni; Eduardo Quintana; Barbara Vidal; David Fuster; Jaume Llopis; Sara Soto; Asuncion Moreno; Francesc Marco; Jose M Miró
Journal:  Antimicrob Agents Chemother       Date:  2017-05-24       Impact factor: 5.191

5.  Extracellular DNA-dependent biofilm formation by Staphylococcus epidermidis RP62A in response to subminimal inhibitory concentrations of antibiotics.

Authors:  Jeffrey B Kaplan; Saïd Jabbouri; Irina Sadovskaya
Journal:  Res Microbiol       Date:  2011-03-12       Impact factor: 3.992

6.  In vitro effects of antimicrobial agents on planktonic and biofilm forms of Staphylococcus lugdunensis clinical isolates.

Authors:  Kristi L Frank; Emily J Reichert; Kerryl E Piper; Robin Patel
Journal:  Antimicrob Agents Chemother       Date:  2006-12-11       Impact factor: 5.191

7.  Role of the Staphylococcus epidermidis slime layer in experimental tunnel tract infections.

Authors:  C C Patrick; M R Plaunt; S V Hetherington; S M May
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

Review 8.  From clinical microbiology to infection pathogenesis: how daring to be different works for Staphylococcus lugdunensis.

Authors:  Kristi L Frank; José Luis Del Pozo; Robin Patel
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

9.  Effects of azithromycin in combination with vancomycin, daptomycin, fosfomycin, tigecycline, and ceftriaxone on Staphylococcus epidermidis biofilms.

Authors:  Elisabeth Presterl; Stefan Hajdu; Andrea M Lassnigg; Alexander M Hirschl; Johannes Holinka; Wolfgang Graninger
Journal:  Antimicrob Agents Chemother       Date:  2009-05-18       Impact factor: 5.191

10.  In vitro biofilm forming potential of Streptococcus suis isolated from human and swine in China.

Authors:  Guo Dawei; Wang Liping; Lu Chengping
Journal:  Braz J Microbiol       Date:  2012-06-01       Impact factor: 2.476

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.